Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
BIOD [NASD]
Biodel Inc.
Index- P/E- EPS (ttm)-0.60 Insider Own0.80% Shs Outstand22.70M Perf Week1.55%
Market Cap44.49M Forward P/E- EPS next Y-1.13 Insider Trans9.00% Shs Float22.43M Perf Month3.16%
Income-12.70M PEG- EPS next Q-0.26 Inst Own19.80% Short Float5.25% Perf Quarter-10.09%
Sales- P/S- EPS this Y35.10% Inst Trans-22.41% Short Ratio7.21 Perf Half Y-39.13%
Book/sh1.01 P/B1.94 EPS next Y-34.50% ROA-44.70% Target Price4.50 Perf Year-60.00%
Cash/sh1.08 P/C1.82 EPS next 5Y- ROE-55.10% 52W Range1.83 - 5.27 Perf YTD-14.04%
Dividend- P/FCF- EPS past 5Y8.60% ROI- 52W High-62.81% Beta2.01
Dividend %- Quick Ratio12.60 Sales past 5Y- Gross Margin- 52W Low7.10% ATR0.08
Employees35 Current Ratio12.60 Sales Q/Q- Oper. Margin- RSI (14)49.08 Volatility3.46% 4.49%
OptionableYes Debt/Eq0.00 EPS Q/Q77.30% Profit Margin- Rel Volume0.52 Prev Close1.93
ShortableYes LT Debt/Eq0.00 EarningsAug 11 AMC Payout- Avg Volume163.11K Price1.96
Recom1.80 SMA201.34% SMA50-1.99% SMA200-19.88% Volume85,155 Change1.55%
10-May-13Upgrade Ladenburg Thalmann Neutral → Buy $6
16-Apr-12Upgrade JMP Securities Mkt Perform → Mkt Outperform $3
26-May-11Initiated Global Hunter Securities Accumulate $5
04-Feb-11Reiterated Wedbush Outperform $7 → $5
10-Dec-10Reiterated Wedbush Outperform $10 → $7
02-Nov-10Reiterated Wedbush Outperform $17 → $10
02-Nov-10Downgrade Ladenburg Thalmann Buy → Neutral $14 → $2
19-Oct-10Initiated JMP Securities Mkt Perform
25-Mar-09Reiterated Wedbush Morgan Buy $10 → $16
25-Mar-09Reiterated Ladenburg Thalmann Buy $9.50 → $14
11-Dec-08Reiterated Ladenburg Thalmann Buy $11 → $9.50
20-Nov-08Reiterated Cantor Fitzgerald Buy $33 → $15
19-Sep-08Downgrade Argus Buy → Sell
11-Sep-08Initiated Oppenheimer Perform
08-Sep-08Reiterated Ladenburg Thalmann Buy $23 → $11
16-May-08Initiated Cantor Fitzgerald Buy $33
02-May-08Initiated Pacific Growth Equities Buy
27-Feb-08Initiated JP Morgan Overweight
25-Feb-08Initiated Punk, Ziegel & Co Buy $23
20-Jun-07Initiated Banc of America Sec Buy $23
27-Aug-14 04:00PM  BIODEL INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
25-Aug-14 04:00PM  Biodel Appoints Gary G. Gemignani as Chief Financial Officer Marketwired
22-Aug-14 01:04PM  BIODEL INC Financials EDGAR Online Financials
14-Aug-14 09:58AM  Biodel Q3 Loss Narrower than Expected, Gives Pipeline Update Zacks
13-Aug-14 05:01PM  BIODEL INC Files SEC form 10-Q, Quarterly Report EDGAR Online
11-Aug-14 05:02PM  [video] Stocks Close Higher, But Off Day's Highs at TheStreet
04:30PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
04:05PM  Biodel Reports Third Quarter Fiscal Year 2014 Financial Results Marketwired
07:30AM  Biodel's insulin drug found effective in trial Reuters
07:07AM  Q3 2014 BIODEL INC Earnings Release - 4:00 pm ET CCBN
07:00AM  Biodel's Concentrated Insulin BIOD-531 Demonstrates Superior Glucose Control Following Standardized Meals Compared to Marketed Insulins in a Phase 2 Clinical Trial in Patients With Type 2 Diabetes Marketwired
06-Aug-14 07:00AM  Biodel to Present at the Wedbush PacGrow Life Sciences Management Access Conference Marketwired
05-Aug-14 07:00AM  Biodel to Report Third Quarter Fiscal Year 2014 Financial Results on August 11, 2014 Marketwired
28-Jul-14 06:00AM  Biodel Enters Into $15 Million Equity Commitment With Lincoln Park Capital Marketwired
11-Jun-14 07:30AM  Biodel to Present at the JMP Securities Healthcare Conference Marketwired
07:30AM  Biodel to Present at the JMP Securities Healthcare Conference
10-Jun-14 07:00AM  Biodel to Present Data on Ultra-Rapid-Acting Insulin and Glucagon Product Candidates at 2014 American Diabetes Association Scientific Sessions Marketwired +5.41%
07:00AM  Biodel to Present Data on Ultra-Rapid-Acting Insulin and Glucagon Product Candidates at 2014 American Diabetes Association Scientific Sessions
23-May-14 04:02PM  BIODEL INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:02PM  BIODEL INC Files SEC form 8-K, Change in Directors or Principal Officers
21-May-14 12:18PM  BIODEL INC Financials EDGAR Online Financials
12:18PM  BIODEL INC Financials
16-May-14 09:20AM  Biodel Q2 Loss Wider Than Expected Zacks
09:20AM  Biodel Q2 Loss Wider Than Expected
14-May-14 05:18PM  BIODEL INC Files SEC form 10-Q, Quarterly Report EDGAR Online
05:18PM  BIODEL INC Files SEC form 10-Q, Quarterly Report
13-May-14 08:44PM  Biodel's (BIOD) CEO Dr. Errol De Souza on Q2 2014 Results - Earnings Call Transcript at Seeking Alpha
08:44PM  Biodel's (BIOD) CEO Dr. Errol De Souza on Q2 2014 Results - Earnings Call Transcript
04:46PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
04:46PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition
04:03PM  Biodel reports Q2 EPS (29c), consensus (24c) at theflyonthewall.com
04:03PM  Biodel reports Q2 EPS (29c), consensus (24c)
04:00PM  Biodel Reports Second Quarter Fiscal Year 2014 Financial Results GlobeNewswire
04:00PM  Biodel Reports Second Quarter Fiscal Year 2014 Financial Results
07:07AM  Q2 2014 BIODEL INC Earnings Release - 4:00 pm ET CCBN
07-May-14 04:00PM  Biodel to Report Second Quarter Fiscal Year 2014 Financial Results on May 13, 2014 GlobeNewswire -5.33%
24-Apr-14 04:30PM  Biodel, HEC Pharm Ink Deal Zacks
22-Apr-14 04:02PM  Biodel announces insulin collaboration pact with HEC Pharm at theflyonthewall.com
04:00PM  Biodel Announces Collaboration Agreement With HEC Pharm for Development of Ultra-Rapid-Acting Insulin Aspart Formulation GlobeNewswire
16-Apr-14 12:30PM  Abbott Labs Tops Earnings, Misses Sales Est Zacks
10-Mar-14 04:06PM  BIODEL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
05-Mar-14 07:04PM  On The Fly: After Hours Movers at theflyonthewall.com
04:00PM  Biodel Announces Commercial Manufacturing Agreement With Emergent BioSolutions for Glucagon Rescue Product GlobeNewswire
04-Mar-14 07:00AM  Biodel to Present at the 26th Annual ROTH Conference GlobeNewswire
14-Feb-14 01:04PM  BIODEL INC Financials EDGAR Online Financials
13-Feb-14 04:40PM  Positive Phase I Data from Biodel Zacks
04:40PM  Positive Phase I Data from Biodel
12-Feb-14 04:30PM  Biodel Announces Plans to Advance BIOD-531 Based on Positive Clinical Trial Results GlobeNewswire
10-Feb-14 04:33PM  BIODEL INC Files SEC form 10-Q, Quarterly Report EDGAR Online +8.66%
01:49PM  Biodel Q1 Loss Narrows Zacks
01:49PM  Biodel Q1 Loss Narrows
07-Feb-14 11:33PM  Biodel's CEO Discusses F1Q 2014 Results - Earnings Call Transcript at Seeking Alpha
11:33PM  Biodel's CEO Discusses F1Q 2014 Results - Earnings Call Transcript
08:15AM  Eight Biotech Stocks Trading Near $5 With Huge Upside Potential at 24/7 Wall St.
08:15AM  Eight Biotech Stocks Trading Near $5 With Huge Upside Potential
06-Feb-14 04:51PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:03PM  Biodel Reports First Quarter Fiscal Year 2014 Financial Results GlobeNewswire
11:40AM  Avanir Reports Narrower Loss, Revs Up Y/Y Zacks
07:07AM  Q1 2014 BIODEL INC Earnings Release - 4:00 pm ET CCBN
05-Feb-14 04:00PM  Biodel to Report First Quarter Fiscal Year 2014 Financial Results on February 6, 2014 GlobeNewswire
04-Feb-14 04:15PM  Biodel to Present at Upcoming Conferences GlobeNewswire
08-Jan-14 09:28AM  Some Stock Ideas For January 2014 at Seeking Alpha
09:28AM  Some Stock Ideas For January 2014
02-Jan-14 01:11PM  5 Stocks Under $10 Set to Soar at TheStreet +21.49%
01:11PM  5 Stocks Under $10 Set to Soar
10:00AM  Biodel Inc: Strong Biotech 'January Effect' Candidate For 2014 at Seeking Alpha
10:00AM  Biodel Inc: Strong Biotech 'January Effect' Candidate For 2014
27-Dec-13 01:04PM  BIODEL INC Financials EDGAR Online Financials
01:04PM  BIODEL INC Financials
11:03AM  Biodel Offers Opportunity in the Growing Insulin, Glucagon Markets TheStreet
11:03AM  Biodel Offers Opportunity in the Growing Insulin, Glucagon Markets at TheStreet
11:03AM  Biodel Offers Opportunity in the Growing Insulin, Glucagon Markets
20-Dec-13 04:03PM  BIODEL INC Files SEC form 10-K, Annual Report EDGAR Online
04:03PM  BIODEL INC Files SEC form 10-K, Annual Report
19-Dec-13 06:03PM  Nasdaq stocks posting largest volume increases AP
18-Dec-13 09:16PM  Biodel's CEO Discusses F4Q 2013 Results - Earnings Call Transcript at Seeking Alpha -5.19%
09:16PM  Biodel's CEO Discusses F4Q 2013 Results - Earnings Call Transcript
04:30PM  Biodel Reports Fourth Quarter Fiscal Year 2013 Financial Results GlobeNewswire
04:30PM  Biodel Reports Fourth Quarter Fiscal Year 2013 Financial Results
04:06PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
04:06PM  BIODEL INC Files SEC form 8-K, Results of Operations and Financial Condition
07:07AM  Q4 2013 BIODEL INC Earnings Release - 4:30 pm ET CCBN
17-Dec-13 06:02PM  Nasdaq stocks posting largest volume increases AP
08:17AM  Biodel Announces Commercial Supply Agreement With BD for Liquid Glucagon Rescue Device GlobeNewswire
12-Dec-13 07:00AM  Biodel to Report Fourth Quarter Fiscal Year 2013 Financial Results on December 18, 2013 GlobeNewswire
07-Nov-13 04:00PM  InPlay: Biodel advances ultra-rapid-acting concentrated insulin formulation into clinical development Briefing.com
04:00PM  Biodel Advances Ultra-Rapid-Acting Concentrated Insulin Formulation Into Clinical Development GlobeNewswire
24-Sep-13 09:55AM  Biodel CEO Buys 10K Shares and 4 Insider Buys to Note at Wall St. Cheat Sheet
19-Sep-13 04:40PM  Is Biodel A Buy Or Sell? at Seeking Alpha
12-Sep-13 10:55AM  Biodel: Creating A Better, Faster Acting Insulin, The Next Big Thing For Diabetic Therapy at Seeking Alpha
11-Sep-13 06:02PM  Nasdaq stocks posting largest volume increases AP -5.51%
10-Sep-13 06:02PM  Nasdaq stocks posting largest volume increases AP
05:30PM  Data on Biodel's BIOD-123 Zacks
09-Sep-13 06:02PM  Nasdaq stocks posting largest volume increases AP -29.82%
02:08PM  Biodel's CEO Presents at Study 3-201Top Line Data Conference Call (Transcript) at Seeking Alpha
12:15PM  Five Highly Unusual Hot Stocks on the Move for Monday 24/7 Wall St.
10:14AM  Biodel Fails to Excite Investors With Me-Too Mealtime Insulin at TheStreet
07:46AM  BIODEL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
01:45AM  InPlay: Biodel: BIOD-123 achieves primary endpoint in Phase 2 Clinical trial demonstrating glycemic control comparable to Humalog Briefing.com
08-Sep-13 07:15PM  When Will Unilife Earnings Go Positive? at Motley Fool
Biodel Inc., a specialty biopharmaceutical company, focuses on the development and commercialization of treatments for diabetes in the United States. It is involved in developing proprietary insulin formulations for type 1 and type 2 diabetes patients; ultra-rapid-acting insulin analog-based formulations; glucagon formulations and presentations for use as a rescue treatment for diabetes patients experiencing severe hypoglycemia or very low concentrations of blood glucose; and other recombinant human insulin-based formulations. The company was founded in 2003 and is headquartered in Danbury, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pereira Brian JGDirectorDec 20Sale2.264,73410,6990Dec 23 07:21 PM